Nestlé Health Science performed better than expected in the first quarter putting it on the right track for the rest of the year.
Nestlé Health Science Beats Expectations In Q1
Nestlé Health Science beat management's expectations in Q1 to post a solid organic sales rise despite facing a high comparative with the prior-year period. While Nestlé's group-wide sales were up in the three months, CEO Mark Schneider warned that further price rises were coming down the track, which would inevitably impact consumer spending.
